March 15, 2012
ST. LOUIS, -- Sigma-Aldrich® Corporation (NASDAQ: SIAL) today announced the opening of its new facility in Wuxi, China, that will provide localized packaging, analytical services and quality control for high-quality products to support the Company's research and industrial customers in the region. "Over the last decade China has invested heavily in industrial growth, and now [...]
March 15, 2012
Bromodomains (BRDs) are 110 amino acid long domains that are found in many chromatin associated proteins. Bromodomains can interact specifically with acetylated lysine. The ability of bromodomain regulators to alter chromatin status and control gene expression is important in the development of certain human cancers, adipogenesis, energy metabolism and inflammation. Bromodomains are emerging as a [...]
Simulations Plus Announces Preliminary Success in Malaria Drug Design Project
March 15, 2012
LANCASTER, Calif -- Simulations Plus, Inc.,a leading provider of consulting services and software for pharmaceutical discovery and development, today announced that preliminary testing shows that one of the molecules it has designed to inhibit the malaria parasite has been shown to be a potent inhibitor of the malaria parasite. Dr. Robert Clark, director of life [...]
March 15, 2012
Irvine, CA- Effective March 15, BioDot Inc is expanding its global reach within Japan. The company has decided to forgo using a distributor supply chain and to staff its own entity. Barbara McIntosh, VP Sales & Marketing of BioDot feels “as BioDot continues to grow, it is critical to us that the message to our [...]
BellBrook Labs’ Novel RGScreen™ Assay Technology is On Target for Parkinson’s Disease
March 15, 2012
Madison, WI -- BellBrook Labs announced today that their RGScreen™ Assay technology for detecting “regulator of G-protein signaling” (RGS) protein activity, can be used to identify inhibitors of the RGS4 protein, which was identified in a groundbreaking new study as a promising target for Parkinson’s disease. The RGScreen™ platform combines genetically engineered G proteins with [...]
ROXY Laboratories Acquires MicroSafe Services from Merck Millipore
March 14, 2012
PROXY Laboratories B.V. (“PROXY”) announces today the acquisition of MicroSafe Services (Leiden, the Netherlands), from Merck Millipore, the Life Science division of Merck KGaA, Darmstadt, Germany. MicroSafe is a microbiological contract laboratory that delivers a complete range of critical testing and consultancy services for the development and production of (bio)pharmaceuticals. In addition to offering the [...]
SiliCycle® Launches Its New SiliaPrepX™ Family of Polymeric SPE Cartridges and Well Plates
March 14, 2012
SiliCycle, primarily renowned as a world leader for its UltraPure silica gels, has created the new SiliaPrepX family of polymeric SPE cartridges and well plates in order to become the one stop shop for all solid-phase extraction treatments. «At SiliCycle, we are committed to offer the best and most diversified product lines for analytical, chromatography [...]
IONICS Mass Spectrometry Launches Second Generation of their Triple Quadrupole Mass Spectrometer
March 14, 2012
Orlando-- IONICS Mass Spectrometry, a leading developer and manufacturer of high performance triple quads, is launching its latest generation of the 3Q Molecular Analyzers the 3Q Series 200 and 3Q Series 100. “We are committed to responding to customer needs and are expanding the product line to meet the market demand” said Erik Hansen, Vice [...]
Polestar Technologies Names Steve Grant as Vice President of Global Sales
March 14, 2012
Needham Heights, MA Polestar Technologies (https://polestartech.com/), a leading provider of innovative sensing technologies and sensor systems for the biotechnology, pharmaceutical, regenerative medicine, biofuels, and food/beverage markets is pleased to name Steve Grant as Vice President of Global Sales. Steve has more than 20 years of sales, sales management, and leadership experience in the field of [...]
March 14, 2012
Goettingen, Germany,-- Thousands of cellular reactions use nucleotides, either alone or in combination with other substrates. Enzymes in the purinome alone – those that use adenine and guanine nucleotides – comprise 13% of the coding capacity of the human genome. Of these, protein kinases have become highly validated drug targets, but lipid kinases, chaperone ATPases [...]
